Mirion Technologies

Mirion Technologies, Inc. engages in the provision of nuclear measurement and detection systems. It offers measurement and enterprise, calibration, customer training programs, installation, product support and repairs, consulting, and instadose desimetry services. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Mirion Technologies posts robust Q4 earnings, eyes SMR market growth

Mirion Technologies reported strong financials, with double-digit revenue growth and a focus on reducing leverage, despite challenges like supply chain issues.
The company's strategic focus on the Medical and Industrial segments, along with opportunities in the SMR market, bode well for future growth.
Balanced growth strategies, disciplined capital allocation, and engagement in key markets position Mirion Technologies for continued success in 2023.

Mirion Technologies reports robust Q1 earnings, eyes growth opportunities

Mirion Technologies delivered strong Q1 results, focusing on operational efficiency, margin improvement, and cash flow generation. The company's rebranding efforts and positive market outlook position it well for future growth. With a history of margin expansion and free cash flow conversion, Mirion is poised for continued success in 2023.

Mirion Technologies posts robust Q2 results and eyes growth opportunities

Mirion Technologies delivered strong Q2 results with positive revenue growth and operational performance.
The company's focus on margin improvement and order intake positions it well for future success.
Despite challenges in pricing dynamics and cash flow, Mirion Technologies remains optimistic about its outlook.

Mirion Technologies excels in Q3 with strong order growth and record backlog

Mirion Technologies delivered a strong Q3 performance with significant order growth and record backlog, supported by strategic acquisitions and operational focus.
While facing challenges in organic growth and margin maintenance, the company remains optimistic about future opportunities for revenue expansion and profitability.
Maintaining financial targets, optimizing cash flow, and emphasizing margin expansion are key priorities for sustained success and market leadership.

Mirion Technologies reports record 2023 results and bullish 2024 guidance

Mirion Technologies had a stellar 2023, setting records in revenue, EBITDA, and free cash flow, with strong guidance for 2024.
The company is strategically focused on margin expansion, cost control, and product innovation to drive future growth.
While facing challenges in healthcare reimbursement and cost management, Mirion is leveraging international markets and new product introductions.
Confidence in achieving growth targets, Mirion remains committed to operational excellence and enhancing shareholder value.

Mirion Technologies reports solid Q1 performance, eyes growth opportunities

Mirion Technologies demonstrated strong financial performance in Q1 2024, driven by key growth drivers in nuclear power and cancer care. Despite challenges in cash flow and margin pressure, the company remains focused on growth opportunities through innovation and strategic initiatives.

Mirion Technologies reports solid Q2 results, eyes growth opportunities

Mirion Technologies showcased solid performance with margin exceeding expectations and raised EBITDA guidance. While facing tough order growth comps, the company is focused on driving organic growth and improving cost structure. Anticipated improvements in Chinese market dynamics and potential positive impact from upcoming CMS changes present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Medical and Technologies segments. The Medical segment consists of sales, products, and services to customers in the medical market. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

Mirion Technologies, Inc. (NYSE:MIR ) Q3 2024 Earnings Conference Call October 30, 2024 11:00 AM ET Company Participants Eric Linn - Investor Relations Thomas Logan - Chairman and Chief Executive Officer Brian Schopfer - Chief Financial Officer Conference Call Participants Joe Ritchie - Goldman Sachs Chris Moore - CJS Securities Andrew Kaplowitz – Citigroup Yuan Zhi - B. Riley Securities Operator Ladies and Gentleman, greetings and welcome to the Mirion Technologies Third Quarter 2024 Earnings Conference Call.

Mirion Technologies, Inc. (MIR) Q3 2024 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2024. “Third quarter results were in-line with our expectations,” stated Thomas Logan, Mirion's Chief Executive Officer. “We continue to see revenue growth and margin expansion across both segments, supported by s.

Mirion Announces Third Quarter 2024 Financial Results and Updates Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced that it has been awarded two significant contracts to support the Sizewell C project, a new 3.2-gigawatt power station for Britain. Leveraging EDF expertise and EPR (European Pressurised Reactor) technology, Sizewell C will generate low-carbon electricity sufficient to power approximately 6 million homes. The development, based in East Suffolk, will mirror the de.

Mirion Technologies Awarded Strategic Contracts for Sizewell C New Nuclear Power Station Project in the UK

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, today announced that it will host an Investor Day on Tuesday, December 3, 2024, beginning at 2:00 p.m. ET. The event will be held at the New York Stock Exchange and webcast live. Due to limited capacity, in-person attendance is by invitation only. Institutional investors and financial analysts wishing to attend in-person should contact ir@mirio.

Mirion to Host Investor Day on December 3, 2024

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for third quarter 2024 after market close on Tuesday, October 29, 2024. Following the news release, the company will host a conference call the next day, Wednesday, October 30, 2024, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be ava.

Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2024

PALO ALTO, Calif. & MELBOURNE, Fla.--(BUSINESS WIRE)-- #SunNuclear--Varian Announces Alliance with Sun Nuclear to Elevate and Expand Quality Assurance Offerings.

Varian Announces Alliance with Sun Nuclear to Elevate and Expand Quality Assurance Offerings

Mirion Technologies, Inc. (NYSE:MIR ) Q2 2024 Earnings Conference Call August 2, 2024 11:00 AM ET Company Participants Jerry Estes - Manager of Investor Relations Thomas Logan - Chairman and Chief Executive Officer Brian Schopfer - Chief Financial Officer Conference Call Participants Joseph Ritchie - Goldman Sachs Christopher Moore - CJS Securities Andrew Kaplowitz - Citi Yuan Zhi - B. Riley Securities Operator Greetings and welcome to the Mirion Technologies Second Quarter 2024 Earnings Conference Call.

Mirion Technologies, Inc. (MIR) Q2 2024 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2024. “Our second quarter results were in-line with our expectations,” stated Thomas Logan, Mirion's Chief Executive Officer. “Both segments delivered steady top-line growth and strong Adjusted EBITDA margin expansion.

Mirion Announces Second Quarter 2024 Financial Results and Updates Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for second quarter 2024 after market close on Thursday, August 1, 2024. Following the news release, the company will host a conference call the next day, Friday, August 2, 2024, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be availabl.

Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2024

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that its management team's presentation at Jefferies' 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event. About Mirion Mirion (NYSE.

Mirion Announces Updated Time of Presentation at Jefferies' 2024 Global Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it completed the redemption of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company's common stock, par value $0.0001 per share (the “Common Shares”), that remained outstanding at 5:00 pm New York City time on Mon.

Mirion Announces Completion of Redemption of its Outstanding Public Warrants

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Jefferies' 2024 Global Healthcare Conference in New York, NY. The presentation will begin at 4:00 PM ET on Thursday, June 6, 2024. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the.

Mirion to Present at Jefferies' 2024 Global Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, previously announced on April 18, 2024, that it will redeem all of its publicly traded warrants (the “Public Warrants”) to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 p.m. New York City time on.

Mirion Reminds Investors of Redemption of Public Warrants

Mirion Technologies, Inc. (NYSE:MIR ) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ET Company Participants Alex Gaddy - Senior Vice President, Strategy and Investor Relations Tom Logan - Chief Executive Officer Brian Schopfer - Chief Financial Officer Conference Call Participants Chris Moore - CJS Securities Vlad Bystricky - Citigroup Andy Kaplowitz - Citigroup Yuan Zhi - B. Riley Securities Operator Hello and welcome to the Mirion Technologies First Quarter 2024 Earnings Conference Call.

Mirion Technologies, Inc. (MIR) Q1 2024 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2024. “The first quarter was a solid start for Mirion in 2024,” stated Thomas Logan, Mirion's Chief Executive Officer. “Revenue growth was in-line with our expectations, led by a strong quarter from our Technologies se.

Mirion Announces First Quarter 2024 Financial Results and Reaffirms Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it will redeem all of its publicly traded warrants to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for.

Mirion Announces Redemption of Public Warrants

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024. Following the news release, the company will host a conference call the next day, Wednesday, May 1, 2024, at 9:00 am ET to discuss the results. Participants may access the call by dialing 1-844-826-3035 or 1-412-317-5195, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available a.

Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities' Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024. About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The M.

Mirion to Present at B. Riley Securities' Radiopharma Day

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe. The event will begin at 9:00 AM ET on Monday, February 26, 2024 and will feature an online portal for investors to submit questions to ask during the event. The presentation will be webcast live at https://www.openexchange.tv/monday-management-update-february-26th/mirion-technologies-inc-nyse-mir.

Mirion to Participate in SHARE Series Fireside Chat on Monday, February 26, 2024

Mirion Technologies, Inc. (MIR) Q4 2023 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2023. Related materials will be available online at ir.mirion.com. “2023 was an excellent year for Mirion. We delivered record revenue and adjusted EBITDA, and substantially improved cash generation a.

Mirion Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Guidance

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi's 2024 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Wednesday, February 21, 2024. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be.

Mirion to Present at Citi's 2024 Global Industrial Tech and Mobility Conference

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024. Following the news release, the company will host a conference call the next day, Wednesday, February 14, 2024, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live web.

Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2023

I invested in Mirion during a time when the sentiment was low, but the thesis was simple. Mirion's products have a crucial role in the nuclear industry and have minimal downside risk. Its addressable market is growing and its products have a moat. Through a combination of acquisitions and organic growth the company has been seeing consistent growth in its topline.

Mirion Technologies: A Good Way To Diversify Uranium Sector Exposure

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world's first critical fast-spectrum salt reactor. This collaboration reinforces TerraPower and Mirion's commitment to fostering sustainable, low-carbon energy solutions that address climate change and support a ne.

News for Mirion Technologies Stock (MIR)